James R Whittle

7PUBLICATIONS
48CO-AUTHORS
Neural engineeringHaematological tumoursMolecular targetsPeople with disabilityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 14, 2026
Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity.

Zachery Moore, Claire Storey, Daniel V Brown

|Aug 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.

James R Whittle, Maria Vieito, Kristoffer Rohrberg

|Aug 21, 2025
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Katharine J Drummond, Montana Spiteri, Sarah A Cain

|May 23, 2025
Co-Designing a User-Centered Digital Health Tool for Supportive Care Needs of Patients With Brain Tumors and Their Caregivers: Interview Analysis.

|Aug 14, 2024
A perioperative study of Safusidenib in patients with IDH1-mutated glioma.

Sarah A Cain, Monique Topp, Mark Rosenthal

|Jun 14, 2023
Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas.

Arian Lasocki, Michael E Buckland, Tahlia Molinaro

Pageof 2

Frequent Collaborators

4 joint publications

Katharine J Drummond

3 joint publications

Saskia Freytag

2 joint publications

Verena Schadewaldt

2 joint publications

Jia-Nan Gong